Phytomedicine as a source of SGLT2 inhibitors, GLP-1 secretagogues and DPP-IV inhibitors for mitigation of Diabetic Nephropathy

Background: Diabetic nephropathy (DN) has been the major contributor to chronic kidney disease (CKD), end stage renal disease (ESRD), and cardiovascular risks. Incretin pathway modulators (GLP-1 analogs, GLP-1R agonist, GLP-1 secretagogues and DPP-IV inhibitors) and SGLT2 inhibitors are presently th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anuj Kumar Borah, Semim Akhtar Ahmed, Jagat C. Borah
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2022-05-01
Colección:Phytomedicine Plus
Materias:
Diabetic nephropathy
GLP-1 secretagogues
DPP-IV inhibitors
SGLT2 inhibitors
Herbal medicine and incretin modulators
Acceso en línea:http://www.sciencedirect.com/science/article/pii/S2667031322000112
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Cargando...

Ejemplares similares